Subbiah V - Search Results

1

Pooled Safety Analysis of Single-Agent Lurbinectedin in Patients With Advanced Solid Tumours.

Leary A, Oaknin A, Trigo JM, Moreno V, Delord JP, Boni V, Braña I, Fernández C, Kahatt C, Nieto A, Cullell-Young M, Zeaiter A, Subbiah V. Leary A, et al. Among authors: subbiah v. Eur J Cancer. 2023 Oct;192:113259. doi: 10.1016/j.ejca.2023.113259. Epub 2023 Jul 28. Eur J Cancer. 2023. PMID: 37634282 Free article.

2

[No title available]

[No authors listed] [No authors listed] PMID: 37916501

3

Searching for clinical trials in oncology: finding a path through the maze.

Desai A, Feldman J, Subbiah V. Desai A, et al. Among authors: subbiah v. Ann Oncol. 2023 Sep;34(9):732-733. doi: 10.1016/j.annonc.2023.06.004. Epub 2023 Jun 27. Ann Oncol. 2023. PMID: 37385470 No abstract available.

4

Sodium fluoride (Na¹⁸F) PET Response Criteria in Solid Tumors (NAFCIST): a framework for response assessment in bone tumors.

Kairemo K, Gouda MA, Buschhorn L, Wahida A, Macapinlac HA, Anderson PM, Subbiah V. Kairemo K, et al. Among authors: subbiah v. ESMO Open. 2023 Aug;8(4):101575. doi: 10.1016/j.esmoop.2023.101575. Epub 2023 Jul 28. ESMO Open. 2023. PMID: 37517365 Free PMC article. Review.

5

Unlocking precision oncology with FGFR inhibition in urothelial carcinoma.

Sonpavde GP, Subbiah V. Sonpavde GP, et al. Among authors: subbiah v. Ann Oncol. 2024 Feb;35(2):150-153. doi: 10.1016/j.annonc.2023.11.006. Epub 2023 Nov 18. Ann Oncol. 2024. PMID: 37981237 No abstract available.

6

Selpercatinib and Pralsetinib Induced Chylous Ascites in RET-Rearranged Lung Adenocarcinoma: A Case Series.

Fricke J, Wang J, Gallego N, Mambetsariev I, Kim P, Babikian R, Chen BT, Afkhami M, Subbiah V, Salgia R. Fricke J, et al. Among authors: subbiah v. Clin Lung Cancer. 2023 Nov;24(7):666-671. doi: 10.1016/j.cllc.2023.08.006. Epub 2023 Aug 6. Clin Lung Cancer. 2023. PMID: 37580188 Free article. No abstract available.

7

Modernize Precision Oncology With Decentralized Trial Tools.

Beg MS, Subbiah V. Beg MS, et al. Among authors: subbiah v. JAMA Oncol. 2024 Apr 1;10(4):427-428. doi: 10.1001/jamaoncol.2023.6786. JAMA Oncol. 2024. PMID: 38358775

8

Variant allele frequency: a decision-making tool in precision oncology?

Boscolo Bielo L, Trapani D, Repetto M, Crimini E, Valenza C, Belli C, Criscitiello C, Marra A, Subbiah V, Curigliano G. Boscolo Bielo L, et al. Among authors: subbiah v. Trends Cancer. 2023 Dec;9(12):1058-1068. doi: 10.1016/j.trecan.2023.08.011. Epub 2023 Sep 12. Trends Cancer. 2023. PMID: 37704501 Review.

9

For what it's worth: the complex area of medicine value assessment.

Ramagopalan SV, Treharne C, Pearson-Stuttard J, Subbiah V. Ramagopalan SV, et al. Among authors: subbiah v. J Comp Eff Res. 2023 Sep;12(9):e230120. doi: 10.57264/cer-2023-0120. Epub 2023 Jul 29. J Comp Eff Res. 2023. PMID: 37515489 Free PMC article. No abstract available.

10

The Impact of Prior Single-Gene Testing on Comprehensive Genomic Profiling Results for Patients with Non-Small Cell Lung Cancer.

Nesline MK, Subbiah V, Previs RA, Strickland KC, Ko H, DePietro P, Biorn MD, Cooper M, Wu N, Conroy J, Pabla S, Zhang S, Wallen ZD, Sathyan P, Saini K, Eisenberg M, Caveney B, Severson EA, Ramkissoon S. Nesline MK, et al. Among authors: subbiah v. Oncol Ther. 2024 Mar 19. doi: 10.1007/s40487-024-00270-x. Online ahead of print. Oncol Ther. 2024. PMID: 38502426 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

578 results

Search Page